Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | PKM | P14618 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CCNC | P24863 | 1/20 | 0.51 |
| ▸ | CDK8 | P49336 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4844382 | 0.85 | ALDH1A1 (0.70) | ALDH1A1PKMMAPTLMNACCNC | |
| SCHEMBL6788102 | 0.85 | ALDH1A1 (0.70) | ALDH1A1PKMMAPTLMNACCNC | |
| SCHEMBL4848737 | 0.82 | ALDH1A1 (0.66) | ALDH1A1PKMMAPTLMNAMEN1 | |
| SCHEMBL4843988 | 0.82 | ALDH1A1 (0.61) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL6792690 | 0.81 | ALDH1A1 (0.65) | ALDH1A1PKMMAPTLMNACCNC | |
| Hydrochloric Acid SCHEMBL6794141 | 0.81 | ALDH1A1 (0.60) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL27583371 | 0.80 | ALDH1A1 (0.62) | ALDH1A1PKMMAPTLMNACCNC | |
| SCHEMBL6794355 | 0.78 | CYP1A2 (0.51) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL5374323 | 0.78 | KMT2A (0.54) | ALDH1A1PKMMAPTLMNAPOLB | |
| SCHEMBL29451986 | 0.77 | L3MBTL1 (0.52) | ALDH1A1PKMMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | ALDH1A1 1427/4885PKM 3447/4885MAPT 4795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.